Home / Inspections / 820739

FDA Inspection 820739 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3006604254

The FDA completed an inspection of Octapharma Plasma Inc on February 6, 2013 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)

Facility

Other inspections at this facility

  • 1153219 (NAI Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009884 (NAI Fri Mar 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 909240 (VAI Thu Jan 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 732180 (VAI Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 608945 (NAI Fri Aug 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources